A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation Mammaplasty

Sponsor
University of Minnesota (Other)
Overall Status
Completed
CT.gov ID
NCT00684749
Collaborator
Mentor Worldwide, LLC (Industry)
142
1
31
4.6

Study Details

Study Description

Brief Summary

At a national level of 15%, the reoperation rate following augmentation mammaplasty is too high. We are conducting a survey to examine the pre-operative methods by which plastic surgeons determine implant volume, size, shape and location; and to determine if the Mentor "BodyLogic"TM System can successfully improve outcomes. We will evaluate how measurements taken using "BodyLogic"TM influence choice of implant and whether there are any re-operations, particularly for size change. We hypothesize that using this system will help surgeons choose appropriate implants that will decrease the rate of reoperations, especially for size change.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    We are planning to survey 10 high volume plastic surgeons that perform at least 10 breast augmentations a month and to collect data on at least 300 patients. The enrollment period will be 3 months.

    As part of this study, we are having the following steps performed:
    1. Complete a 'general preference questionnaire', designed to document current preoperative planning and assessment methods for breast augmentation.

    2. For each study patient, a pre-operative "BodyLogic"TM worksheet will be completed. Then, using the provided Implant Selection Booklet, the actual implant will be selected. The surgeon will maintain a key of the patients, and will identify them to the investigators only by subject number, and return these forms in provided stamped, self-addressed envelopes.

    3. The patient returns at 1-3 months and 8-12 months for completion of the respective "Body-Logic" post-operative worksheets for each visit and the surgeon will send us the data in the provided envelopes periodically.

    4. If during the course of the data collection, the surgeon has to re-operate on any patient, he/she will fill the "re-operative form" and send it to us.

    5. Finally, the surgeon will complete a post-study evaluation questionnaire to help us understand how the "BodyLogic"TM System worked for him/her and how it could be improved.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    142 participants
    Time Perspective:
    Prospective
    Official Title:
    Pilot Study to Investigate The BodyLogic TM System (Mentor) in Breast Augmentation.
    Study Start Date :
    May 1, 2008
    Actual Primary Completion Date :
    Sep 1, 2010
    Actual Study Completion Date :
    Dec 1, 2010

    Outcome Measures

    Primary Outcome Measures

    1. Reoperation Rates [2 years]

      Surgeon completed survey

    Secondary Outcome Measures

    1. Patient Satisfaction With Outcome [1 Year]

      Patient completed a survey regarding outcome

    2. Surgeon Satisfaction With Outcome [1 Year]

      Patient completedsurvey regarding outcome

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    22 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Female (age > 22 years)

    • Cosmetic Breast Augmentation only

    • Primary breast augmentation

    Exclusion Criteria:
    • Breast reconstruction

    • Secondary breast augmentation

    • <22 years of age

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Minnesota Minneapolis Minnesota United States 55455

    Sponsors and Collaborators

    • University of Minnesota
    • Mentor Worldwide, LLC

    Investigators

    • Principal Investigator: Umar H Choudry, MD, University of Minnesota

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Minnesota
    ClinicalTrials.gov Identifier:
    NCT00684749
    Other Study ID Numbers:
    • 0801E25711
    First Posted:
    May 28, 2008
    Last Update Posted:
    Feb 23, 2015
    Last Verified:
    Feb 1, 2015

    Study Results

    Participant Flow

    Recruitment Details Surgeons recruited their own patients in their own offices
    Pre-assignment Detail as above.
    Arm/Group Title Total Population
    Arm/Group Description All surgical patients
    Period Title: Overall Study
    STARTED 142
    COMPLETED 142
    NOT COMPLETED 0

    Baseline Characteristics

    Arm/Group Title Total Population
    Arm/Group Description All surgical patients
    Overall Participants 142
    Age (Count of Participants)
    <=18 years
    0
    0%
    Between 18 and 65 years
    142
    100%
    >=65 years
    0
    0%
    Sex: Female, Male (Count of Participants)
    Female
    142
    100%
    Male
    0
    0%

    Outcome Measures

    1. Primary Outcome
    Title Reoperation Rates
    Description Surgeon completed survey
    Time Frame 2 years

    Outcome Measure Data

    Analysis Population Description
    All patients who were treated in the time period
    Arm/Group Title Total Population
    Arm/Group Description All surgical patients
    Measure Participants 142
    Number [participants]
    6
    4.2%
    2. Secondary Outcome
    Title Patient Satisfaction With Outcome
    Description Patient completed a survey regarding outcome
    Time Frame 1 Year

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description
    3. Secondary Outcome
    Title Surgeon Satisfaction With Outcome
    Description Patient completedsurvey regarding outcome
    Time Frame 1 Year

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description

    Adverse Events

    Time Frame
    Adverse Event Reporting Description
    Arm/Group Title Total Population
    Arm/Group Description All surgical patients
    All Cause Mortality
    Total Population
    Affected / at Risk (%) # Events
    Total / (NaN)
    Serious Adverse Events
    Total Population
    Affected / at Risk (%) # Events
    Total 0/142 (0%)
    Other (Not Including Serious) Adverse Events
    Total Population
    Affected / at Risk (%) # Events
    Total 0/142 (0%)

    Limitations/Caveats

    snap shot view, responder bias

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Umar Choudry/Bruce Cunningham
    Organization University of Minnesota
    Phone 6126250697
    Email choud008@umn.edu
    Responsible Party:
    University of Minnesota
    ClinicalTrials.gov Identifier:
    NCT00684749
    Other Study ID Numbers:
    • 0801E25711
    First Posted:
    May 28, 2008
    Last Update Posted:
    Feb 23, 2015
    Last Verified:
    Feb 1, 2015